Annovis Bio, Inc. Shareholders' Equity
Annovis Bio, Inc. (ANVS) had Shareholders' Equity of -$4.25 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$4.25M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $3.13M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $16.85M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $13.16M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$4.25M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $3.13M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $16.85M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $13.16M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $18.33M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $24.05M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $9.31M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $7.06M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$1.75M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | -$3.35M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | -$7.75M 10-K · filed 2026-03-13 | |
| 2023-09-30 | $6.66M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $20.74M 10-Q · filed 2024-11-08 | |
| 2023-03-31 | $20.14M 10-Q · filed 2024-11-08 | |
| 2022-12-31 | $28.32M 10-K · filed 2025-03-21 | |
| 2022-09-30 | $34.59M 10-Q · filed 2023-11-08 | $29.96M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $38.67M 10-Q · filed 2023-11-08 | $35.23M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $42.70M 10-Q · filed 2023-11-08 | $42.04M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $44.49M 10-K · filed 2024-03-29 | |
| 2021-09-30 | $46.53M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $48.61M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $4.37M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $7.54M 10-K · filed 2023-03-31 | |
| 2020-09-30 | $9.12M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $9.50M 10-Q · filed 2021-11-03 | |
| 2020-03-31 | $10.69M 10-Q · filed 2021-11-03 | |
| 2019-12-31 | -$8.58M 10-K · filed 2022-03-02 | |
| 2019-09-30 | -$8.37M 10-Q · filed 2020-11-04 | |
| 2019-06-30 | -$8.12M 10-Q · filed 2020-11-04 | |
| 2019-03-31 | -$7.78M 10-Q · filed 2020-11-04 | |
| 2018-12-31 | -$7.59M 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |